ArticleLeukemia & lymphoma2014

The histone deacetylase inhibitor SAHA sensitizes acute myeloid leukemia cells to a combination of nucleoside analogs and the DNA-alkylating agent busulfan.

Guiyun Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.